https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05841238-2026-07-10 Hipa.ai en 2026-07-10T00:00:00.000Z Orforglipron Phase 1 PK Study Shows Dose-Dependent Exposure in Healthy… https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct03929744-2026-07-10 Hipa.ai en 2026-07-10T00:00:00.000Z Orforglipron Phase 1 Study in Healthy Participants: No Related SAEs https://hipa.ai/drug/cbl-514/updates/trial-results-posted-nct05836779-2026-07-09 Hipa.ai en 2026-07-09T00:00:00.000Z CBL-514 Phase 2 Study Shows Improvement in Cellulite Severity https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct02009449-2026-07-09 Hipa.ai en 2026-07-09T00:00:00.000Z Pegilodecakin Phase 1 Trial Safety Data Posted for Advanced Solid Tumors https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-janumet-label-effective-2026-07-2026-07-09 Hipa.ai en 2026-07-09T00:00:00.000Z Invokamet XR Label Adds Metformin-Associated Lactic Acidosis Boxed Warning https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct05715216-2026-07-08 Hipa.ai en 2026-07-08T00:00:00.000Z Nivolumab Combo Shows 15-30% ORR in Platinum-Resistant Ovarian Cancer https://hipa.ai/drug/dulaglutide/updates/trial-results-posted-nct04255433-2026-07-08 Hipa.ai en 2026-07-08T00:00:00.000Z Dulaglutide: Tirzepatide Shows Fewer MACE-3 Events in Type 2 Diabetes Trial https://hipa.ai/drug/adalimumab/updates/boxed-warning-present-label-adalimumab-label-effective-2026-2026-07-08 Hipa.ai en 2026-07-08T00:00:00.000Z Adalimumab Label Updated with Boxed Warning for Serious Infections, Malignancy https://hipa.ai/drug/adalimumab/updates/boxed-warning-revised-yuflyma-label-effective-2026-07-08-2026-07-08 Hipa.ai en 2026-07-08T00:00:00.000Z Adalimumab (Yuflyma) Boxed Warning Revised for Serious Infections, Malignancy https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-extended-2026-07-07 Hipa.ai en 2026-07-07T00:00:00.000Z Metformin Hydrochloride Extended Release Boxed Warning Revised for Lactic… https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-07-07 Hipa.ai en 2026-07-07T00:00:00.000Z Metformin Hydrochloride Boxed Warning Revised for Lactic Acidosis Risk